Full-Time
Global pharmaceutical company providing medicines
No salary listed
Senior, Expert
San Antonio, TX, USA
In Person
Viatris is a global pharmaceutical company that provides access to a wide range of medicines, including branded and generic drugs, complex generics, and biosimilars. The company operates by leveraging its extensive global commercial infrastructure and supply chain to deliver high-quality medications to patients in over 165 countries. Viatris generates revenue through the sale of its pharmaceutical products, focusing on key therapeutic areas such as cardiovascular health, infectious diseases, immunology, and oncology. What sets Viatris apart from its competitors is its commitment to addressing public health challenges, particularly the increasing prevalence of non-communicable diseases. The company's goal is to achieve organic growth through its existing product offerings while also pursuing strategic partnerships and acquisitions to expand its reach and impact in the healthcare sector.
Company Size
10,001+
Company Stage
IPO
Headquarters
Canonsburg, Pennsylvania
Founded
1961
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Paid Holidays
Biocon's acquisition of Viatris for $3.3 billion marks a potential turning point for the company, which has seen muted growth. Despite revenue growth, concerns about debt, equity dilution, and valuation persist. Biocon's business now includes biosimilars, contract research, and generics. The company plans to raise ₹4,500 crore through a Qualified Institutional Placement to reduce its ₹17,756 crore debt. A potential merger with Biocon Biologics Ltd could unlock further value.
PITTSBURGH, May 7, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on June 16, 2025, to shareholders of record as of the close of business on May 23, 2025.About ViatrisViatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris
PITTSBURGH, March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally
PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.A live webcast of the event at can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally
PITTSBURGH, Feb. 27, 2025 /PRNewswire/ --